Literature DB >> 6738766

Bone histology and calcium metabolism in patients with nephrotic syndrome and normal or reduced renal function.

N Tessitore, E Bonucci, A D'Angelo, B Lund, A Corgnati, B Lund, E Valvo, A Lupo, C Loschiavo, A Fabris.   

Abstract

Bone histology and its relationship with calcium metabolism was evaluated in adult patients with nephrotic syndrome: 29 had normal renal function (GFR 103 +/- 4 ml/min/1.73 m2) (group 1) and 20 had renal insufficiency (GFR 31 +/- 4 ml/min/1.73 m2) (group 2). In group 1, serum PTH, 1.25-HCC and 24.25-HCC levels were normal, while 25-HCC values were reduced. Bone histology was normal in 76% of the patients, while 17% had isolated osteomalacia and 7% an associated bone resorption. Group 2 showed a higher incidence of bone resorption when compared with a matched group of patients with renal failure and no proteinuria (40% vs. 13%) and a comparable frequency of isolated mineralization defect (25% vs. 34%). PTH levels were definitely increased and serum total calcium and all the vitamin D metabolites were reduced. A significant correlation between the apparent duration of the disease and the severity of osteodystrophy was found only in group 2. In conclusion, no constant derangement of calcium metabolism and bone histology is evident in patients with nephrotic syndrome and normal renal function, while patients with persistent proteinuria are at high risk of osteodystrophy even in the early phases of renal failure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6738766     DOI: 10.1159/000183236

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  6 in total

1.  Vitamin D metabolites in childhood nephrotic syndrome.

Authors:  U S Alon
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

Review 2.  Bone Health in Glomerular Kidney Disease.

Authors:  Dorey A Glenn; Michelle R Denburg
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

3.  Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission.

Authors:  Francis L Weng; Justine Shults; Rita M Herskovitz; Babette S Zemel; Mary B Leonard
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

4.  Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.

Authors:  Mustafa Bak; Erkin Serdaroglu; Rengin Guclu
Journal:  Pediatr Nephrol       Date:  2005-12-29       Impact factor: 3.714

5.  Bone histology in steroid-treated children with non-azotemic nephrotic syndrome.

Authors:  Michael Freundlich; Michael Jofe; William G Goodman; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2004-02-26       Impact factor: 3.714

6.  Calcium, Vitamin D, and Bone Derangement in Nephrotic Syndrome.

Authors:  Samantha Peiling Yang; Lizhen Ong; Tze Ping Loh; Horng Ruey Chua; Cassandra Tham; Khoo Chin Meng; Lim Pin
Journal:  J ASEAN Fed Endocr Soc       Date:  2021-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.